Essential thrombocytosis: diagnostic and treatment dilemmas.
Essential thrombocytosis is one of the chronic myeloproliferative disorders that includes polycythemia vera, chronic myelogenous leukemia, and agnogenic myeloid metaplasia. Despite established diagnostic criteria and greater than a quarter century of study, there are still several diagnostic and management dilemmas that plague researchers and clinicians alike. We present a case of essential thrombocytosis in a patient with multiple sequelae.
Dugan
Veronica
V
Department of Internal Medicine, Louisiana State University, School of Medicine, New Orleans, USA.
Higginbotham
Raphael
R
Gilbert
Jill
J
Lipscomb
Gary
G
Lopez
Fred A
FA
D001241:Aspirin / Q000627:therapeutic use; D002908:Chronic Disease; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000627:therapeutic use; D018570:Risk Assessment; D013922:Thrombocytosis / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D034061:Thrombopoiesis / Q000502:physiology
D016898:Interferon-alpha; D011799:Quinazolines; C021139:anagrelide; D001241:Aspirin; D006918:Hydroxyurea